medline.ch Onkologie Gynäkologische Tumoren

	Comparing multifocality to unifocal breast cancer and the relation to survival: a national cohort study. Br J Surg Söderberg E, Wärnberg F Prof, Wennstig AK, Nilsson G, Garmo H, Holmberg L Prof, Sund M Prof, Wadsten C. PMID: 42012264 [PubMed - as supplied by publisher]
	Anxiety and screening attitudes in breast cancer patients and their first-degree relatives: A comparative pilot study. Turk J Surg Karamese B, Durukan ST, Sana EB, Sabouni R, Uysal AB, Sever N, Bayoglu IV, H, Tazegul G. PMID: 42012099 [PubMed - as supplied by publisher]
	Preliminary study on targeted nanoparticles co-loaded with piperine and paclitaxel prodrug for ovarian cancer treatment. J Mater Chem B Wang S, Liao Y, Yang B, Li L, Xi M. PMID: 42011733 [PubMed - as supplied by publisher]
	Sustained Effects of a 6-Week Resiliency Program for Women with Metastatic Breast Cancer: A Brief Report of a Clinical Trial. J Palliat Med Henneghan A, Wertheimer J, Kim S, Gresham G, Shirazipour CH, Jones B, Asher A. PMID: 42011526 [PubMed - as supplied by publisher]
	Long-term outcome of isolated locoregional (ILRR) breast cancer (BC) recurrence: a large retrospective Mono-institutional study. Oncologist Vernaci G, Griguolo G, Girardi F, Menichetti A, Ferrucci M, Marchet A, Bellu L, Faggioni G, Falci C, Landa G, Commare M, Giarratano T, Giorgi CA, Guarneri V, Dieci MV. PMID: 42011506 [PubMed - as supplied by publisher]
	The role of stereotactic body radiotherapy in oligoprogressive breast cancer: A site-specific analysis of the prospective, phase-II RADIANT trial. Clin Transl Radiat Oncol Ruicci KM, Helou J, Barry A, Ye XY, Koch CA, Croke J, Han K, Rodin D, Hahn E, Kwan JYY, Yan M, Liu FF, Lindsay P, Javor J, Bedard P, Cescon D, Kumar V, Amir E, Nadler MB, Lee R, Glicksman RM. PMID: 42011409 [PubMed - as supplied by publisher]
	Capecitabine versus Paclitaxel After CDK4/6 Inhibitor Progression in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Real-World Study. Breast Cancer (Dove Med Press) Birsin Z, Güren AK, Aliyev V, Guliyev M, Jeral S, Cebeci S, Çerme E, Günalt, Abbasov H, Çiçek E, Atak S, Sar, Demirci NS, Alan Ö. PMID: 42011243 [PubMed]
	High Prevalence of Non-BRCA Pathogenic Variants and a Recurrent PALB2 Variant in an Argentine Hereditary Breast and Ovarian Cancer Cohort. Cancer Med Martin CA, Bono C, Mandrile J, Kunst CSM, Borello AE, Ávila R, Salazar FC, Miretti V, Pabletich F, Andreoli V, Ceschin DG. PMID: 42011088 [PubMed - indexed for MEDLINE]
	A novel methodology using direct patient contact and UK national registries to collect long-term data from randomised trials: TARGIT-X - an extended follow-up study of the TARGIT-A trial of targeted intraoperative radiotherapy for breast cancer. Health Technol Assess Vaidya JS, Williams NR, Bulsara M, Brew-Graves C, Potyka I, Roberts N, Lindsay J, Laws S, Raj S, Douek M, Falzon M, Petralia G, Needleman S, Malhotra A, Bernstein M, Tobias JS. PMID: 42011087 [PubMed - as supplied by publisher]
	Vascular Endothelial Growth Factor/Angiopoietin-2 Bispecific Antibody-Induced Vascular Normalization: From Basic Mechanisms to Therapeutic Applications in Breast Cancer. Immun Inflamm Dis Li M, Han F, Ling S, Su X, Zhao Y, Lv S, Zhang X. PMID: 42011047 [PubMed - as supplied by publisher]
	Novel Influence Diagnostics in Multistate Models for Breast Cancer. Stat Med Leiva-Yamaguchi V, Tapia A, Galea M, Rueda OM. PMID: 42011007 [PubMed - as supplied by publisher]
	A comparative study of molecular characteristics of pathogenic and uncertain significance variants of BRCA1/2 in Chinese breast cancer patients. BMC Res Notes Guan J, Hu J, Lin S, Chen C, Luo Y, Zhou W. PMID: 42010629 [PubMed - as supplied by publisher]
	Barriers to surgical treatment and diagnostic intervals among women with operable breast cancer in Benin: a retrospective study from two referral centers (2019-2023). World J Surg Oncol Gnangnon FHR, Vodouhè T, Gogan RPC, Acakpo B, Djohou SFJ, Aboubakar M, Gbessi DG, Tonato-Bagnan JA, Denakpo JL, Aguemon CT. PMID: 42010554 [PubMed - as supplied by publisher]
	Multicenter prospective study of dedicated breast positron emission tomography (dbPET) for breast cancer: examination in preoperative patients. BMC Med Imaging Satou Y, Nakagami Y, Suga K, Yamaguchi Breast Cancer Study Group (YBC). PMID: 42010499 [PubMed - as supplied by publisher]
	From Seed to Therapy: Sesamin and Phytosterols of Sesamum indicum in Polycystic Ovary Syndrome and Ovarian Cancer. Reprod Sci Shah FI, Butt SK, Akram F, Shehzadi S, Ali H, Sabir S. PMID: 42010142 [PubMed - as supplied by publisher]
	Development of machine learning and nomogram models to predict lung metastasis and prognosticate survival in breast cancer. Discov Oncol Bai R, Zeng Y, Lin F, Zhang L. PMID: 42010136 [PubMed - as supplied by publisher]
	Descriptive study of stromal expression of CD73 in ductal carcinoma in situ of the breast. Discov Oncol Catteau X, Noël JC, Fallas J, Charry M, Denis Z, De Caluwé A, Stagg J, Sotiriou C, Buisseret L. PMID: 42010032 [PubMed - as supplied by publisher]
	Triple-negative breast cancer with neurofibromatosis type 1: management challenges. BMJ Case Rep Fatima I, Jaffarsadiq A, Faquih AE, Hlavacek C, Sehbai A. PMID: 42009450 [PubMed - indexed for MEDLINE]
	Accurate diagnosis of triple-negative breast cancer enables temperature-compensation all optical microfibre gratings system. Biosens Bioelectron Liu X, Xu Q, Wang Y, Wang C, Liang W, Huang L, Lu L, Lv J, Gao J, Yu B, Li H. PMID: 42008957 [PubMed - as supplied by publisher]
	Durvalumab in Combination With Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: Long-Term Analysis From the GeparNuevo Trial. J Clin Oncol Loibl S, Untch M, Huober J, Schaser V, Braun M, Denkert C, Hartkopf A, Blohmer JU, Hanusch C, Link T, Reinisch M, Zahm DM, Weide R, Bjelic-Radisic V, Staib P, Tesch H, Rhiem K, Lorenz R, Rey J, Schneeweiss A. PMID: 42008768 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 327525

Seite 1 von 16377

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung